Acute cholestatic hepatitis associated with long-term use of rofecoxib.
Papachristou
Georgios I
GI
Department of Medicine, Division of Gastroenterology and Hepatology, University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania 15213, USA.
Demetris
Anthony J
AJ
Rabinovitz
Mordechai
M
D000208:Acute Disease; D000368:Aged; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000473:pathology; D002779:Cholestasis / Q000139:chemically induced* / Q000473:pathology; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007783:Lactones / Q000009:adverse effects* / Q000627:therapeutic use; D013450:Sulfones
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib